Literature DB >> 33148792

Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions.

Shijian Zhang1,2, Hanh T Nguyen1,2, Haitao Ding3,4, Jia Wang1, Shitao Zou1, Lihong Liu5, Debjani Guha1, Dana Gabuzda1,6, David D Ho5, John C Kappes3,4, Joseph Sodroski7,2.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) trimer is transported through the secretory pathway to the infected cell surface and onto virion particles. In the Golgi, the gp160 Env precursor is modified by complex sugars and proteolytically cleaved to produce the mature functional Env trimer, which resists antibody neutralization. We observed mostly uncleaved gp160 and smaller amounts of cleaved gp120 and gp41 Envs on the surface of HIV-1-infected or Env-expressing cells; however, cleaved Envs were relatively enriched in virions and virus-like particles (VLPs). This relative enrichment of cleaved Env in VLPs was observed for wild-type Envs, for Envs lacking the cytoplasmic tail, and for CD4-independent, conformationally flexible Envs. On the cell surface, we identified three distinct populations of Envs: (i) the cleaved Env was transported through the Golgi, was modified by complex glycans, formed trimers that cross-linked efficiently, and was recognized by broadly neutralizing antibodies; (ii) a small fraction of Env modified by complex carbohydrates escaped cleavage in the Golgi; and (iii) the larger population of uncleaved Env lacked complex carbohydrates, cross-linked into diverse oligomeric forms, and was recognized by poorly neutralizing antibodies. This last group of more "open" Env oligomers reached the cell surface in the presence of brefeldin A, apparently bypassing the Golgi apparatus. Relative to Envs transported through the Golgi, these uncleaved Envs were counterselected for virion incorporation. By employing two pathways for Env transport to the surface of infected cells, HIV-1 can misdirect host antibody responses toward conformationally flexible, uncleaved Env without compromising virus infectivity.IMPORTANCE The envelope glycoprotein (Env) trimers on the surface of human immunodeficiency virus type 1 (HIV-1) mediate the entry of the virus into host cells and serve as targets for neutralizing antibodies. The cleaved, functional Env is incorporated into virus particles from the surface of the infected cell. We found that an uncleaved form of Env is transported to the cell surface by an unconventional route, but this nonfunctional Env is mostly excluded from the virus. Thus, only one of the pathways by which Env is transported to the surface of infected cells results in efficient incorporation into virus particles, potentially allowing the uncleaved Env to act as a decoy to the host immune system without compromising virus infectivity.
Copyright © 2021 American Society for Microbiology.

Entities:  

Keywords:  Env; Golgi bypass; antibody; cell surface; cleavage; trafficking; virion incorporation

Mesh:

Substances:

Year:  2021        PMID: 33148792      PMCID: PMC7925103          DOI: 10.1128/JVI.01369-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  180 in total

1.  HIV vaccine design and the neutralizing antibody problem.

Authors:  Dennis R Burton; Ronald C Desrosiers; Robert W Doms; Wayne C Koff; Peter D Kwong; John P Moore; Gary J Nabel; Joseph Sodroski; Ian A Wilson; Richard T Wyatt
Journal:  Nat Immunol       Date:  2004-03       Impact factor: 25.606

2.  HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.

Authors:  Philip R Tedbury; Mariia Novikova; Ayna Alfadhli; Yuta Hikichi; Ioannis Kagiampakis; Vineet N KewalRamani; Eric Barklis; Eric O Freed
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

3.  CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

Authors:  A Trkola; T Dragic; J Arthos; J M Binley; W C Olson; G P Allaway; C Cheng-Mayer; J Robinson; P J Maddon; J P Moore
Journal:  Nature       Date:  1996-11-14       Impact factor: 49.962

4.  Native Conformation and Canonical Disulfide Bond Formation Are Interlinked Properties of HIV-1 Env Glycoproteins.

Authors:  Eden P Go; Albert Cupo; Rajesh Ringe; Pavel Pugach; John P Moore; Heather Desaire
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

5.  Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope Proteins.

Authors:  Elisabeth Braun; Dominik Hotter; Lennart Koepke; Fabian Zech; Rüdiger Groß; Konstantin M J Sparrer; Janis A Müller; Christian K Pfaller; Elena Heusinger; Rebecka Wombacher; Kathrin Sutter; Ulf Dittmer; Michael Winkler; Graham Simmons; Martin R Jakobsen; Karl-Klaus Conzelmann; Stefan Pöhlmann; Jan Münch; Oliver T Fackler; Frank Kirchhoff; Daniel Sauter
Journal:  Cell Rep       Date:  2019-05-14       Impact factor: 9.423

6.  Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  T Dorfman; F Mammano; W A Haseltine; H G Göttlinger
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  The antigenic structure of the HIV gp120 envelope glycoprotein.

Authors:  R Wyatt; P D Kwong; E Desjardins; R W Sweet; J Robinson; W A Hendrickson; J G Sodroski
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

8.  Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector.

Authors:  Andrea L Szymczak; Creg J Workman; Yao Wang; Kate M Vignali; Smaroula Dilioglou; Elio F Vanin; Dario A A Vignali
Journal:  Nat Biotechnol       Date:  2004-04-04       Impact factor: 54.908

9.  HIV-1 Env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations.

Authors:  Xiaochu Ma; Maolin Lu; Jason Gorman; Daniel S Terry; Xinyu Hong; Zhou Zhou; Hong Zhao; Roger B Altman; James Arthos; Scott C Blanchard; Peter D Kwong; James B Munro; Walther Mothes
Journal:  Elife       Date:  2018-03-21       Impact factor: 8.140

10.  Rab11-FIP1C and Rab14 direct plasma membrane sorting and particle incorporation of the HIV-1 envelope glycoprotein complex.

Authors:  Mingli Qi; Janice A Williams; Hin Chu; Xuemin Chen; Jaang-Jiun Wang; Lingmei Ding; Ehiole Akhirome; Xiaoyun Wen; Lynne A Lapierre; James R Goldenring; Paul Spearman
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

View more
  11 in total

1.  Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer.

Authors:  Shijian Zhang; Kunyu Wang; Wei Li Wang; Hanh T Nguyen; Shuobing Chen; Maolin Lu; Eden P Go; Haitao Ding; Robert T Steinbock; Heather Desaire; John C Kappes; Joseph Sodroski; Youdong Mao
Journal:  J Virol       Date:  2021-09-22       Impact factor: 5.103

2.  Global Increases in Human Immunodeficiency Virus Neutralization Sensitivity Due to Alterations in the Membrane-Proximal External Region of the Envelope Glycoprotein Can Be Minimized by Distant State 1-Stabilizing Changes.

Authors:  Qian Wang; Florian Esnault; Meiqing Zhao; Ta-Jung Chiu; Amos B Smith; Hanh T Nguyen; Joseph G Sodroski
Journal:  J Virol       Date:  2022-03-15       Impact factor: 6.549

3.  Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation.

Authors:  Hanh T Nguyen; Alessandra Qualizza; Saumya Anang; Meiqing Zhao; Shitao Zou; Rong Zhou; Qian Wang; Shijian Zhang; Ashlesha Deshpande; Haitao Ding; Ta-Jung Chiu; Amos B Smith; John C Kappes; Joseph G Sodroski
Journal:  J Virol       Date:  2022-03-28       Impact factor: 6.549

4.  Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects.

Authors:  Hanh T Nguyen; Shijian Zhang; Qian Wang; Saumya Anang; Jia Wang; Haitao Ding; John C Kappes; Joseph Sodroski
Journal:  J Virol       Date:  2020-12-11       Impact factor: 5.103

5.  HIV-1 Envelope Glycoproteins Proteolytic Cleavage Protects Infected Cells from ADCC Mediated by Plasma from Infected Individuals.

Authors:  Jérémie Prévost; Halima Medjahed; Dani Vézina; Hung-Ching Chen; Beatrice H Hahn; Amos B Smith; Andrés Finzi
Journal:  Viruses       Date:  2021-11-06       Impact factor: 5.818

6.  Truncation of the Cytoplasmic Tail of Equine Infectious Anemia Virus Increases Virion Production by Improving Env Cleavage and Plasma Membrane Localization.

Authors:  Xue-Feng Wang; Yu-Hong Wang; Bowen Bai; Mengmeng Zhang; Jie Chen; Xiangmin Zhang; Min Gao; Xiaojun Wang
Journal:  J Virol       Date:  2021-09-08       Impact factor: 5.103

7.  ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection.

Authors:  Dieter Mielke; Gama Bandawe; Jie Zheng; Jennifer Jones; Melissa-Rose Abrahams; Valerie Bekker; Christina Ochsenbauer; Nigel Garrett; Salim Abdool Karim; Penny L Moore; Lynn Morris; David Montefiori; Colin Anthony; Guido Ferrari; Carolyn Williamson
Journal:  PLoS Pathog       Date:  2021-11-17       Impact factor: 6.823

Review 8.  Membrane Interference Against HIV-1 by Intrinsic Antiviral Factors: The Case of IFITMs.

Authors:  Federico Marziali; Andrea Cimarelli
Journal:  Cells       Date:  2021-05-11       Impact factor: 6.600

9.  HIV-1 Envelope Glycoprotein Cell Surface Localization Is Associated with Antibody-Induced Internalization.

Authors:  Sai Priya Anand; Jérémie Prévost; Jade Descôteaux-Dinelle; Jonathan Richard; Dung N Nguyen; Halima Medjahed; Hung-Ching Chen; Amos B Smith; Marzena Pazgier; Andrés Finzi
Journal:  Viruses       Date:  2021-09-29       Impact factor: 5.818

Review 10.  The HIV Env Glycoprotein Conformational States on Cells and Viruses.

Authors:  Connie Zhao; Hongru Li; Talia H Swartz; Benjamin K Chen
Journal:  mBio       Date:  2022-03-24       Impact factor: 7.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.